Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Rubello

Showing results (271-280 of 471) with videos related to

Pageof 48
Sort By:
Nuclear Medicine Communications|November 7, 2008
Radiation emission dose from patients administered 90Y-labelled radiopharmaceuticals: comparison of experimental measurements versus Monte Carlo simulationSergio Lo Meo, Gianfranco Cicoria, Giancarlo Montini, et al.
Nuclear Medicine Communications|January 21, 2015
Response criteria for malignant lymphomaAnna M Maffione, Rossella Paolini, Elisabetta Rodella, et al.
Molecular Imaging and Biology|August 12, 2010
68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumoursMeeran Naji, Chunlei Zhao, Sarah J Welsh, et al.
Clinical Nuclear Medicine|May 23, 2007
Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patientsMaria Rosa Pelizzo, Isabella Merante Boschin, Antonio Toniato, et al.
Nuclear Medicine Communications|May 29, 2004
Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experienceMaria Rosa Pelizzo, Isabella Merante Boschin, Antonio Toniato, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 20, 2018
Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndromeAlberto Mazza, Salvatore Lenti, Laura Schiavon, et al.
World Journal of Clinical Oncology|October 25, 2011
FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case seriesLaura Evangelista, Nadia Sorgato, Francesca Torresan, et al.
Clinical Nuclear Medicine|July 24, 2013
Role of SPECT/CT in sentinel lymph node detection in patients with breast cancerLaetitia Vercellino, Jessica Ohnona, David Groheux, et al.
Nuclear Medicine Communications|March 17, 2012
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticalsKa Kit Wong, Amanda M Laird, Amir Moubayed, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2008
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumoursValentina Ambrosini, Paola Tomassetti, Paolo Castellucci, et al.
Pageof 48

Showing results (271-280 of 471) with videos related to

Sort By:
Pageof 48
Nuclear Medicine Communications|November 7, 2008
Radiation emission dose from patients administered 90Y-labelled radiopharmaceuticals: comparison of experimental measurements versus Monte Carlo simulationSergio Lo Meo, Gianfranco Cicoria, Giancarlo Montini, et al.
Nuclear Medicine Communications|January 21, 2015
Response criteria for malignant lymphomaAnna M Maffione, Rossella Paolini, Elisabetta Rodella, et al.
Molecular Imaging and Biology|August 12, 2010
68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumoursMeeran Naji, Chunlei Zhao, Sarah J Welsh, et al.
Clinical Nuclear Medicine|May 23, 2007
Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patientsMaria Rosa Pelizzo, Isabella Merante Boschin, Antonio Toniato, et al.
Nuclear Medicine Communications|May 29, 2004
Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experienceMaria Rosa Pelizzo, Isabella Merante Boschin, Antonio Toniato, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 20, 2018
Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndromeAlberto Mazza, Salvatore Lenti, Laura Schiavon, et al.
World Journal of Clinical Oncology|October 25, 2011
FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case seriesLaura Evangelista, Nadia Sorgato, Francesca Torresan, et al.
Clinical Nuclear Medicine|July 24, 2013
Role of SPECT/CT in sentinel lymph node detection in patients with breast cancerLaetitia Vercellino, Jessica Ohnona, David Groheux, et al.
Nuclear Medicine Communications|March 17, 2012
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticalsKa Kit Wong, Amanda M Laird, Amir Moubayed, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2008
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumoursValentina Ambrosini, Paola Tomassetti, Paolo Castellucci, et al.
Pageof 48